4//SEC Filing
Thoren Natasha Fay 4
Accession 0001628280-25-034233
CIK 0001501697other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:21 PM ET
Size
5.5 KB
Accession
0001628280-25-034233
Insider Transaction Report
Form 4
Thoren Natasha Fay
Chief Legal Officer
Transactions
- Award
Common Stock
2025-05-20+3,333→ 9,462 total
Footnotes (2)
- [F1]Grant of restricted stock units to the Reporting Person under the Issuer's Amended and Restated 2017 Equity Incentive Plan with each restricted stock unit representing the right to receive one share of common stock on the applicable vesting date. No amount was paid upon the grant of the restricted stock units. The restricted stock units vest in three equal annual installments on May 10, 2026, May 10, 2027 and May 10, 2028, subject to the Reporting Person continuing to provide service as an employee of the Issuer through such date.
- [F2]The reported amount has been adjusted to reflect a correction to the number of shares beneficially owned by the Reporting Person, which was inadvertently overstated by 855 shares on the Form 3 filed on June 3, 2025.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0002070977
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:21 PM ET
- Size
- 5.5 KB